Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.
Apr 17, 2024
0
0
Africa is experiencing unprecedented growth in terms of both population and economic transformation.
Apr 16, 2024
0
0
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
1
If you are scrambling to get your child's attention-deficit/hyperactivity disorder prescription refilled, you are definitely not alone. Families across the U.S. have been dealing with an ADHD medication shortage first reported ...
Apr 15, 2024
0
2
A team of researchers led by Kim Hong Ji and Woo Choong-Wan at the Center for Neuroscience Imaging Research (CNIR) within the Institute for Basic Science (IBS), in collaboration with Emily FINN at Dartmouth College, has unlocked ...
Apr 11, 2024
0
30
Cancer cases are increasing among young people, with rising instances of colorectal cancer in people under age 55 and cervical cancer diagnoses ticking up for women ages 33 to 44, according to the American Cancer Society.
Apr 10, 2024
0
0
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Americans seem to have quite a positive view of dietary supplements. According to a 2023 survey, 74% of U.S. adults take vitamins, prebiotics and the like.
Apr 8, 2024
0
0
Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.
Apr 4, 2024
0
1
New research carried out by Kent's Center for Health Services Studies as part of the Health Behavior of School Age Children Survey (HBSC) for England has found that cyberbullying among school-aged children has risen, with ...
Apr 4, 2024
0
0
